Covax

India to play the most important role in bringing COVID-19 pandemic to end, says USAID administrator

India will resume the export of surplus coronavirus vaccines in October under the ''Vaccine Maitri'' programme to meet its commitment to the COVAX global pool

Quad supplies 79 million COVID-19 vaccine doses to Indo-Pacific nations

The Quad leaders, in joint statement, said due to the Quad Vaccine Partnership's financing of increased manufacturing capacity at the Hyderabad-based Biological E LTD, additional production in India will be on cards later this year

WHO chief Tedros Ghebreyesus hails India's decision to resume COVID vaccine exports

Health Minister Mansukh Mandaviya has said vaccinating Indian citizens remains the topmost priority of the government

India to resume exporting surplus COVID-19 vaccines in October, says health minister Mansukh Mandaviya

Addressing the media, the minister said the government will receive over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the next three months.

Rich countries with abundant vaccine supplies should refrain from administering booster shot till years: WHO chief

“We don’t want any more promises. We just want the vaccines,” the WHO chief said.

India pulled back vaccine supply to COVAX due to surge of cases inside country, says USAID administrator

The shortage is going to end soon as the US has purchased the Pfizer vaccine, which will start to come online in August, Samantha Power told a Congressional Committee

COVID-19: WHO chief asks countries to vaccinate 10% of population by Sept; why rapid vaccination is crucial

According to a UN report, COVID-19 vaccination rates are uneven across countries, ranging from below 1% of the population in some countries to above 60% in others

US announces allocation plan for tranche of 55 million COVID-19 vaccine doses, including 16 million to Asia

With the earlier allocation of 25 million, the Biden administration has so far pledged to distribute 80 million doses by the end of June

Novavax claims large study in US and Mexico finds its COVID-19 vaccine about 90% effective

The vaccine was similarly effective against several variants including the one first detected in the UK, and in high-risk populations

UNICEF's five reasons why COVID-19 vaccine donations are essential

The chance of a more deadly SAR-CoV-2 variant cropping up into existence increases the longer the virus spreads.